Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender

Lipids

Volumn 41, Issue 12, 2006, Pages 1141-1149

  Ogborn, Malcolm R ^a,c   Nitschmann, Evan ^a   Bankovic Calic, Neda ^a   Weiler, Hope A ^b   Aukema, Harold M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYSTIC KIDNEY DISEASE (PKD); RENAL INJURY; SECOISOLARICINORESINOL DYGLYCOSIDE (SDG);

BIOCONVERSION; NUTRITION; OILS AND FATS; PEROXIDES; PHOSPHOLIPIDS;

DISEASES;

CORN OIL; GLYCOSIDE; LIGNAN DERIVATIVE; LINSEED OIL; LIPID PEROXIDE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; SECOISOLARICINORESINOL DIGLYCOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FEMALE; GAS CHROMATOGRAPHY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; LIPID ANALYSIS; LIPID COMPOSITION; MALE; NEPHRITIS; NONHUMAN; NUTRIENT; PROSTAGLANDIN RELEASE; PROTEINURIA; RAT; SEX DIFFERENCE;

ANIMALS; CORN OIL; DISEASE MODELS, ANIMAL; FATTY ACIDS, UNSATURATED; FEMALE; FLAX; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION TESTS; LIGNANS; LINSEED OIL; MALE; PHYTOTHERAPY; POLYCYSTIC KIDNEY DISEASES; PROSTAGLANDINS E; RATS; SEX FACTORS;

ANIMALIA; LINUM USITATISSIMUM; RATTUS; ZEA MAYS;

EID: 33846200824     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-5064-z     Document Type: Article

References (50)

1. Burrowes, J.D., and Van Houten, G. (2005) Use of Alternative Medicine by Patients with Stage 5 Chronic Kidney Disease, Adv. Chronic Kidney Dis. 12, 312-325.
2. Bierenbaum, M.L., Reichstein, R., and Watkins, T.R. (1993) Reducing Atherogenic Risk in Hyperlipemic Humans with Flax Seed Supplementation: A Preliminary Report, J. Am. Coll. Nutr. 12, 501-504.
3. Ford, J.D., Huang, K.S., Wang, H.B., Davin, L.B., and Lewis, N.G. (2001 ) Biosynthetic Pathway to the Cancer Chemopreventive Secoisolariciresinol Diglucoside-Hydroxymethyl Glutaryl Ester-Linked Lignan Oligomers in Flax (Linum usitatissimum) Seed, J. Nat. Prod. 64, 1388-1397.
4. Jenkins, D.J., Kendall, C.W., Vidgen, E., Agarwal, S., Rao, A.V., Rosenberg, R.S., Diamandis, E.P., Novokmet, R., Mehling, C.C., Perera, T., Griffin, L.C., and Cunnane, S.C. (1999) Health Aspects of Partially Defatted Flaxseed, Including Effects on Serum Lipids, Oxidative Measures, and ex vivo Androgen and Progestin Activity: A Controlled Crossover Trial, Am. J. Clin. Nutr. 69, 395-402.
5. Prasad, K. (1997) Dietary Flax Seed in Prevention of Hypercholesterolemic Atherosclerosis, Atherosclerosis 132, 69-76.
6. Rossetti, R.G., Seiler, C.M., DeLuca, P., Laposata, M., and Zurier, R.B. (1997) Oral Administration of Unsaturated Fatty Acids: Effects on Human Peripheral Blood T Lymphocyte Proliferation, J. Leukoc. Biol. 62, 438-443.
7. Gibson, R.A., Neumann, M.A., James, M.J., Hawkes, J.S., Hall, C., and Cleland, L.G. (1992) Effect of n-3 and n-6 Dietary Fats on the Lipoxygenase Products from Stimulated Rat Neutrophils, Prostaglandins Leukot. Essent. Fatty Acids 46, 87-91.
8. Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., and James, M.J. (1996) The Effect on Human Tumor Necrosis Factor Alpha and Interleukin 1 Beta Production of Diets Enriched in n-3 Fatty Acids from Vegetable Oil or Fish Oil, Am. J. Clin. Nutr. 63, 116-122.
9. Borriello, S.P., Setchell, K.D., Axelson, M., and Lawson, A.M. (1985) Production and Metabolism of Lignans by the Human Fecal Flora, J. Appl. Bacteriol. 58, 37-43.
10. Kurzer, M.S., and Xu, X. (1997) Dietary Phytoestrogens, Annu. Rev. Nutr. 17, 353-381.
11. Velasquez, M.T., Bhathena, S.J., Ranich, T., Schwartz, A.M., Kardon, D.E., Ali, A.A., Haudenschild, C.C., and Hansen, C.T. (2003) Dietary Flaxseed Meal Reduces Proteinuria and Ameliorates Nephropathy in an Animal Model of Type II Diabetes Mellitus, Kidney Int. 64, 2100-2107.
12. Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Buist, R., and Peeling, J. (1998) The Effect of Dietary Flaxseed Supplementation on Organic Anion and Osmolyte Content and Excretion in Rat Polycystic Kidney Disease, Biochem. Cell Biol. 76, 553-559.
13. Ogborn, M.R., Nitschmann, E., Weiler, H., Leswick, D., and Bankovic-Calic, N. (1999) Flaxseed Ameliorates Interstitial Nephritis in Rat Polycystic Kidney Disease, Kidney Int. 55, 417-423.
14. Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Weiler, H.A., and Aukema, H. (2002) Dietary Flax Oil Reduces Renal Injury, Oxidized LDL Content, and Tissue n-6/n-3 FA Ratio in Experimental Polycystic Kidney Disease, Lipids 37, 1059-1065.
15. Ingram, A.J., Parbtani, A., Clark, W.F., Spanner, E., Huff, M.W., Philbrick, D.J., and Holub, B.J. (1995) Effects of Flaxseed and Flax Oil Diets in a Rat-5/6 Renal Ablation Model, Am. J. Kidney Dis. 25, 320-329.
16. Hall, A.V., Parbtani, A., Clark, W.F., Spanner, E., Keeney, M., Chin Yee, I., Philbrick, D.J., and Holub, B.J. (1993) Abrogation of MRL/1pr Lupus Nephritis by Dietary Flaxseed, Am. J. Kidney Dis. 22, 326-332.
17. Clark, W.F., Parbtani, A., Huff, M.W., Spanner, E., de Salis, H., Chin Yee, I., Philbrick, D.J., and Holub, B.J. (1995) Flaxseed: A Potential Treatment for Lupus Nephritis, Kidney Int. 48, 475-480.
18. Gabow, P.A., Johnson, A.M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T., and Jones, R.H. (1992) Factors Affecting the Progression of Renal Disease in Autosomal-Dominant Polycystic Kidney Disease, Kidney Int. 41, 1311-1319.
19. Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P., Dicks, E., Parfrey, P., Torra, R., San-Millan, J.L., Goto, E., Van Dijk, M., Breuning, M., Peters, D., Bogdanova, N., Ligabue, G., Albertazzi, A., Hateboer, N., Demetriou, K., Pierides, A., Deltas, C., St. George-Hyslop, P., Ravine, D., and Pei, Y. (2003) Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease, J. Am. Soc. Nephrol. 14, 1164-1174.
20. Yium, J., Gabow, P., Johnson, A., Kimberling, W., and Martinez-Maldonado, M. (1994) Autosomal Dominant Polycystic Kidney Disease in Blacks: Clinical Course and Effects of Sickle-Cell Hemoglobin, J. Am. Soc. Nephrol. 4, 1670-1674.
21. Kausz, A.T., Obrador, G.T., Arora, P., Ruthazer, R., Levey, A.S., and Pereira, B.J. (2000) Late Initiation of Dialysis Among Women and Ethnic Minorities in the United States, J. Am. Soc. Nephrol. 11, 2351-2357.
22. Kang, A.K., and Miller, J.A. (2003) Impact of Gender on Renal Disease: the Role of the Renin Angiotensin System, Clin. Invest. Med. 26, 38-44.
23. Kang, D.H., Yu, E.S., Yoon, K.I., and Johnson, R. (2004) The Impact of Gender on Progression of Renal Disease: Potential Role of Estrogen-Mediated Vascular Endothelial Growth Factor Regulation and Vascular Protection, Am. J. Pathol. 164, 679-688.
24. Montezano, A.C., Callera, G.E., Mota, A.L., Fortes, Z.B., Nigro, D., Carvalho, M.H., Zorn, T.M., and Tostes, R.C. (2005) Endothelin-1 Contributes to the Sexual Differences in Renal Damage in DOCA-Salt Rats, Peptides 26, 1454-1462.
25. Neugarten, J., and Silbiger, S.R. (1995) Effects of Sex Hormones on Mesangial Cells, Am. J. Kidney Dis. 26, 147-151.
26. Reyes, D., Lew, S.Q., and Kimmel, P.L. (2005) Gender Differences in Hypertension and Kidney Disease, Med. Clin. North Am. 89, 613-630.
27. Modification of Diet in Renal Disease Study Group. (1995) Dietary Protein Restriction, Blood Pressure Control, and the Progression of Polycystic Kidney Disease, J. Am. Soc. Nephrol. 5, 2037-2047.
28. Knight, E.L., Stampfer, M.J., Hankinson, S.E., Spiegelman, D., and Curhan, G.G. (2003) The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency, Ann. Intern. Med. 138, 460-467.
29. Gretz, N., Ceccherini, I., Kranzlin, B., Kloting, I., Devoto, M., Rohmeiss, P., Hocher, B., Waldherr, R., and Romeo, G. (1995) Gender-Dependent Disease Severity in Autosomal Polycystic Kidney Disease of Rats, Kidney Int. 48, 496-500.
30. Cowley, B.D., Jr., Rupp, J.C., Muessel, M.J., and Gattone, V.H., II. (1997) Gender and the Effect of Gonadal Hormones on the Progression of Inherited Polycystic Kidney Disease in Rats, Am. J. Kidney Dis. 29, 265-272.
31. Ogborn, M.R., Nitschmann, E., Weiler, H.A., and Bankovic-Calic, N. (2000) Modification of Polycystic Kidney Disease and Fatty Acid Status by Soy Protein Diet, Kidney Int. 57, 159-166.
32. Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Weiler, H., and Aukema, H. (2005) Flax and Soy Phytoestrogen Effects on Renal Injury and Lipid Content in Experimental Polycystic Kidney Disease, J. Am. Nutr. Assoc. 8, 26-32.
33. Bosmans, J.L., Holvoet, P., Dauwe, S.E., Ysebaert, O.K., Chapelle, T., Jurgens, A., Kovacic, V., Van Marck, E.A., De Broe, M.E., and Verpooten, G.A. (2001) Oxidative Modification of Low-Density Lipoproteins and the Outcome of Renal Allografts at 1 1/2 Years, Kidney Int. 59, 2346-2356.
34. Uauy, R.D., Birch, D.G., Birch, E.E., Tyson, J.E., and Huffman, D.R. (1990) Effect of Dietary Omega-3 Fatty Acids on Retinal Function of Very-Low-Birth-Weight Neonates, Pediatr. Res. 28, 485-492.
35. Mathias, M.M., and Dupont, J. (1985) Quantitative Relationships Between Dietary Linoleate and Prostaglandin (Eicosanoid) Biosynthesis, Lipids 20, 791-801.
36. Kivits, G.A., and Nugteren, D.H. (1988) The Urinary Excretion of Prostaglandins E and Their Corresponding Tetranor Metabolites by Rats Fed a Diet Rich in Eicosapentaenoate, Biochim. Biophys. Acta 958, 289-299.
37. Nagao, S., Kusaka, M., Nishii, K., Marunouchi, T., Kurahashi, H., Takahashi, H., and Grantham, J. (2005) Androgen Receptor Pathway in Rats with Autosomal Dominant Polycystic Kidney Disease, J. Am. Soc. Nephrol. 16, 2052-2062.
38. Zeier, M., Pohlmeyer, G., Deerberg, F., Schonherr, R., and Ritz, E. (1994) Progression of Renal Failure in the Han:SPRD Polycystic Kidney Rat, Nephrol. Dial. Transplant 9, 1734-1739.
39. Sullivan, J.C., Sasser, J.M., Pollock, D.M., and Pollock, J.S. (2005) Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats, Hypertension 45, 406-411.
40. Yang, T., Huang, Y.G., Ye, W., Hansen, P., Schnermann, J.B., and Briggs, J.P. (2005) Influence of Genetic Background and Gender on Hypertension and Renal Failure in COX-2-Deficient Mice, Am. J. Physiol. Renal Physiol. 288, F1125-1132.
41. Breyer, M.D., and Breyer, R.M. (2000) Prostaglandin E Receptors and the Kidney, Am. J. Physiol. Renal Physiol. 279, F12-23.
42. Vukicevic, S., Simic, P., Borovecki, F., Grgurevic, L., Rogic, D., Orlic, I., Grasser, W.A., Thompson, D.D., and Paralkar, V.M. (2006) Role of EP2 and EP4 Receptor-Selective Agonists of Prostaglandin E(2) in Acute and Chronic Kidney Failure, Kidney Int. 70, 1099-1106.
43. Eddy, A.A., and Giachelli, C.M. (1995) Renal Expression of Genes That Promote Interstitial Inflammation and Fibrosis in Rats with Protein-Overload Proteinuria, Kidney Int. 47, 1546-1557.
44. Frazier-Jessen, M., and Kovacs, E. (1995) Estrogen Modulation of JE/Monocyte Chemoattractant Protein-1 mRNA Expression in Murine Macrophages, J. Immunol. 154, 1838-1845.
45. Bankovic-Calic, N., Eddy, A., Sareen, S., and Ogborn, M.R. (1999) Renal Remodelling in Dietary Protein Modified Rat Polycystic Kidney Disease, Pediatr. Nephrol. 13, 567-570.
46. Krepinsky, J., Ingram, A.J., James, L., Ly, H., Thai, K., Cattran, D.C., Miller, J.A., and Scholey, J.W. (2002) 17beta-Estradiol Modulates Mechanical Strain-Induced MAPK Activation in Mesangial Cells, J. Biol. Chem. 277, 9387-9394.
47. Concolino, G., Lubrano, C., Ombres, M., Santonati, A., Flammia, O.P., and Di Silverio, F. (1993) Acquired Cystic Kidney Disease: The Hormonal Hypothesis, Urology 41, 170-175.
48. Silbiger, S.R., and Neugarten, J. (2003) The Role of Gender in the Progression of Renal Disease, Adv. Ren. Replace Ther. 10, 3-14.
49. Donadio, J.V., Jr. (2000) Use of Fish Oil to Treat Patients with Immunoglobulin a Nephropathy, Am. J. Clin. Nutr. 71, 373S-375S.
50. Clark, W.F., Muir, A.D., Westcott, N.D., and Parbtani, A. (2000) A Novel Treatment for Lupus Nephritis: Lignan Precursor Derived from Flax, Lupus 9, 429-436.